Skip to content

Person-checked company records fromPerson-checked records $750See a worked exampleHuman review in progress

Talk to sales

KeptIndex

Disc Medicine, Inc.

Start the confirmatory APOLLO study for bitopertin

Delivered by the deadline

AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.

Announced
9 Dec 2024
Due
30 Jun 2025
Delivered
May 2025
  • Deadline
  • Met
  • Late
  • Not met
  • Today

What the company said

“confirmatory APOLLO study starting by mid-2025”

What we found

Evidence strength A What the grades mean

The company initiated the confirmatory APOLLO clinical trial for bitopertin in May 2025, which is before the mid-2025 deadline.

  • A
    Disc Medicine, Inc. 10-Q filed 2025-08-07 Regulatory filing · published 7 Aug 2025 · retrieved 1 Oct 2026 · kept permanently by the SEC · fingerprint 53d7fac14eed
    “We initiated the APOLLO trial in May 2025.” ✓ confirmed on the page
  • A
    Disc Medicine, Inc. 10-Q filed 2025-08-07 Regulatory filing · published 7 Aug 2025 · retrieved 1 Oct 2026 · kept permanently by the SEC · fingerprint 53d7fac14eed
    “The increase of $22.8 million was primarily due to an increase of $16.6 million in bitopertin development expense, including a $10.0 million milestone payment triggered by the initiation of our APOLLO trial.” ✓ confirmed on the page

Market reaction: the shares moved -1.2% against the S&P 500 over the three sessions around the disclosure (6 Aug 2025 to 11 Aug 2025). What this measures

Checked 1 Oct 2026.

Commitment DNA

The structured record of this commitment. Fields the company did not state are left blank rather than guessed.

Event type
Clinical milestone
Indicative materiality
Medium rules
Action
Start
Deliverable
APOLLO study
In the company’s control
High
Specificity
High

How this entry was checked

  1. Commitment recordedThe company's words were matched word for word against the filing.
  2. First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
  3. Second check: disagreesClaude (Anthropic) re-read the evidence blind and read it as “Late”.
  4. Tie-breakA stronger model read the evidence and both earlier answers, without knowing which was recorded, and agrees with the recorded outcome.

Confirmed. This outcome counts towards the company's Kept Score. How verification works

Are you Disc Medicine, Inc.? You can publish an official statement next to this entry, free. Add a statement.

Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.

Report an error in this entry Reference: KI-C-2024-IRON-002181 · Corrections policy

The Deadline Report

One email a week: the corporate commitments that came due, which were met, which slipped, and what is due next. Free. Stop any time.

No advertising. We never sell or share your address.